Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility

PLoS Genetics

Volumn 7, Issue 5, 2011, Pages

  Zhao, Jian ^a   Wu, Hui ^a   Khosravi, Melanie ^a   Cui, Huijuan ^b   Qian, Xiaoxia ^b   Kelly, Jennifer A ^c   Kaufman, Kenneth M ^c,d   Langefeld, Carl D ^e   Williams, Adrienne H ^e   Comeau, Mary E ^e   Ziegler, Julie T ^e   Marion, Miranda C ^e   Adler, Adam ^c   Glenn, Stuart B ^c   Alarcón Riquelme, Marta E ^c,f   BIOLUPUS Network, ^a   GENLES Network, ^a   Pons Estel, Bernardo A ^g   Harley, John B ^h,i   Bae, Sang Cheol ^j   Bang, So Young ^j   Cho, Soo Kyung ^j   Jacob, Chaim O ^k   Vyse, Timothy J ^l   Niewold, Timothy B ^m   Gaffney, Patrick M ^c   Moser, Kathy L ^c   Kimberly, Robert P ⁿ   Edberg, Jeffrey C ⁿ   Brown, Elizabeth E ^n,o   Alarcon, Graciela S ⁿ   Petri, Michelle A ^p   Ramsey Goldman, Rosalind ^q   Vilá, Luis M ^r   Reveille, John D ^s   James, Judith A ^c,t   Gilkeson, Gary S ^u   Kamen, Diane L ^u   Freedman, Barry I ^e   Anaya, Juan Manuel ^v   Merrill, Joan T ^c   Criswell, Lindsey A ^w   Scofield, R Hal ^c,d,t   Stevens, Anne M ^x,y   Guthridge, Joel M ^c   Chang, Deh Ming ^z   Song, Yeong Wook ^aa   Park, Ji Ah ^aa   Lee, Eun Young ^aa   Boackle, Susan A ^ab   Grossman, Jennifer M ^a   Hahn, Bevra H ^a   Goodship, Timothy H J ^ac   Cantor, Rita M ^a   Yu, Chack Yung ^ad   Shen, Nan ^b   Tsao, Betty P ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^f UNIVERSITY OF GRANADA   (Spain)

^g Sanatorio Parque   (Argentina)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l KING'S COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF CHICAGO   (United States)

ⁿ University of Alabama at Birmingham   (United States)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q NORTHWESTERN UNIVERSITY   (United States)

^r UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^s UNIVERSITY OF TEXAS   (United States)

^t UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^u MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^v UNIVERSIDAD DEL ROSARIO   (Colombia)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^y SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^z NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^aa Seoul National University   (South Korea)

^ab UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^ac NEWCASTLE UNIVERSITY   (United Kingdom)

^ad OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 1; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 2; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 3; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 4; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 5; PLASMA PROTEIN; UNCLASSIFIED DRUG; BLADDER TUMOR ASSOCIATED ANTIGEN; BLADDER TUMOR-ASSOCIATED ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

AFRICAN AMERICAN; ARTICLE; CASE CONTROL STUDY; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 1 GENE; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 2 GENE; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 3 GENE; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 4 GENE; COMPLEMENT REGULATOR FACTOR H RELATED PROTEIN 5 GENE; CONTROLLED STUDY; ETHNICITY; EUROPEAN AMERICAN; GENE; GENE DELETION; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ALLELE; ASIAN; CAUCASIAN; CHROMOSOME 1; ETHNOLOGY; GENE FREQUENCY; GENETICS; GENOTYPE; HISPANIC;

ADULT; AGED; ALLELES; CARBON; DNA DAMAGE; DNA METHYLATION; FEMALE; GENETIC VARIATION; GENOTYPE; HISTONES; HUMANS; METHYLATION; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TELOMERE; TELOMERE-BINDING PROTEINS; AFRICAN AMERICANS; ANTIGENS, NEOPLASM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; COMPLEMENT FACTOR H; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; INTRONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TUMOR MARKERS, BIOLOGICAL;

EID: 79957991917     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002079     Document Type: Article

References (39)

1. Rahman A, Isenberg DA, (2008) Systemic lupus erythematosus. N Engl J Med 358: 929-939.
2. Manderson AP, Botto M, Walport MJ, (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22: 431-456.
3. Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, et al. (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19: 1272-1280.
4. Miyagawa H, Yamai M, Sakaguchi D, Kiyohara C, Tsukamoto H, et al. (2008) Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 47: 158-164.
5. Rhodes B, Hunnangkul S, Morris DL, Hsaio LC, Graham DS, et al. (2009) The heritability and genetics of complement C3 expression in UK SLE families. Genes Immun 10: 525-530.
6. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, et al. (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80: 1037-1054.
7. de Cordoba SR, de Jorge EG, (2008) Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 151: 1-13.
8. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P, (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41: 355-367.
9. Jozsi M, Zipfel PF, (2008) Factor H family proteins and human diseases. Trends Immunol 29: 380-387.
10. Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse HM, et al. (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114: 2439-2447.
11. Bao L, Haas M, Quigg RJ, (2011) Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol 22: 285-295.
12. Johanneson B, Lima G, von Salome J, Alarcon-Segovia D, Alarcon-Riquelme ME, (2002) A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am J Hum Genet 71: 1060-1071.
13. Wu H, Boackle SA, Hanvivadhanakul P, Ulgiati D, Grossman JM, et al. (2007) Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A 104: 3961-3966.
14. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
15. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
16. Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, et al. (2007) Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 204: 1249-1256.
17. Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, et al. (2006) Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet 43: 582-589.
18. Davila S, Wright VJ, Khor CC, Sim KS, Binder A, et al. (2010) Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 42: 772-776.
19. Zipfel PF, Edey M, Heinen S, Jozsi M, Richter H, et al. (2007) Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 3: e41 doi:10.1371/journal.pgen.0030041.
20. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, et al. (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38: 1173-1177.
21. Deng Y, Tsao BP, (2010) Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 6: 683-692.
22. Clark SJ, Higman VA, Mulloy B, Perkins SJ, Lea SM, et al. (2006) His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem 281: 24713-24720.
23. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, et al. (2007) Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 204: 2277-2283.
24. Skerka C, Lauer N, Weinberger AA, Keilhauer CN, Suhnel J, et al. (2007) Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol 44: 3398-3406.
25. Tortajada A, Montes T, Martinez-Barricarte R, Morgan BP, Harris CL, et al. (2009) The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum Mol Genet 18: 3452-3461.
26. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, et al. (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38: 1049-1054.
27. Maller J, George S, Purcell S, Fagerness J, Altshuler D, et al. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38: 1055-1059.
28. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, et al. (2008) Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet 17: 971-977.
29. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, et al. (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31: 424-428.
30. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, et al. (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16: 1392-1403.
31. Fritsche LG, Lauer N, Hartmann A, Stippa S, Keilhauer CN, et al. (2010) An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet 19: 4694-4704.
32. Dallegri F, Ottonello L, (1997) Tissue injury in neutrophilic inflammation. Inflamm Res 46: 382-391.
33. Bao L, Osawe I, Puri T, Lambris JD, Haas M, et al. (2005) C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol 35: 2496-2506.
34. Baumann U, Chouchakova N, Gewecke B, Kohl J, Carroll MC, et al. (2001) Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J Immunol 167: 1022-1027.
35. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, et al. (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58: 309-314.
36. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, et al. (2005) Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16: 555-563.
37. Jozsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, et al. (2007) Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 110: 1516-1518.
38. Hochberg MC, (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
39. Lessard CJ, Adrianto I, Kelly JA, Kaufman KM, Grundahl KM, et al. (2011) Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet 88: 83-91.